An anesthesiologist and a cardiologist gave up prestigious careers to save their daughter from war. Nearly four years later, they’re still on the long road to practicing their professions in the ...
An anesthesiologist and a cardiologist gave up prestigious careers to save their daughter from war. Nearly four years later, they’re still on the long road to practicing their professions in Wisconsin ...
Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver ...
Bridge to Life gets US FDA De Novo clearance for VitaSmart HOPE System, the first device cleared in the US for hypothermic oxygenated perfusion of donor livers: Duluth, Georgia We ...
RenovoRx, Inc . (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted ...
MedPage Today on MSN
Stroke Trial Tips Scale Further to Favor Intra-Arterial Lytic After EVT
CHOICE-2 supports intra-arterial alteplase after successful reperfusion ...
This milestone reflects our ability to deliver specialized recovery, logistics, and technology support...needed to ...
Researching are throwing lots of ideas at the wall to see what sticks, but the U.S. just put some serious cash behind the idea of 3D bioprinting.
United Therapeutics Corporation uses strong cash flows to develop xenotransplanted organs and solve global supply shortages.
(“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted oncology therapies and ...
Annexin Pharmaceuticals AB today announces favourable findings in the company's ongoing Proof of Concept Phase 2a study with the drug candidate ANXV in Diabetic Retinopathy (DR) and Retinal Vein Occlu ...
Johns Hopkins scientists and partners across the country are conducting research that could dramatically improve transplants, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results